Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access.

• Autores: Stewart Landers, Farzana Kapadia
• Localización: American journal of public health, ISSN 0090-0036, Vol. 107, Nº. 10, 2017, págs. 1534-1535
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The article discusses research on the use of the drug Truvada as preexposure prophylaxis (PrEP) to prevent HIV transmission. The funding of PrEP is addressed in relation to the previous funding of highly active antiretroviral therapy (HAART) through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) in low- and middle-income nations. U.S. state policy, as well as plans in Brazil, are noted in relation to PrEP funding for high-risk people.